a-ads798

Search This Blog

nativeadstera

aads970+250

729adst

798+90yilix

admetex 790+90

ad2bitcoin 728+90

zerads 728+90

aads468+60

zerads 468+60

admetex 460+60

aadsadaptabl

mob ylix

468+60asdster

468+60yilix

aads referal

ad2bit460+60

OBJECTIVE: The goal of this study was to determine the incidence of postoperative tachycardia and its predictive value of

 


Abstract

OBJECTIVE: The goal of this study was to determine the incidence of postoperative tachycardia and its predictive value of complications in patients following microvascular free flap surgery in the head and neck.

STUDY DESIGN: Retrospective chart review.

SETTING: Single tertiary care academic medical center.

SUBJECTS AND METHODS: All patients who underwent a microvascular free flap of the head and neck by surgeons in the department of otolaryngology from 2013 to 2017 were included in this study.

RESULTS: Of the 344 who patients met inclusion criteria, 40.4% had a maximum heart rate (HR) of the hospitalization over 110 beats per minute (bpm). Patients with a maximum HR greater than 110 bpm were 19 times more likely to experience a composite vascular complication (myocardial infarction, myocardial necrosis, or pulmonary embolism) than patients with a maximum HR <110

CONCLUSION: Postoperative tachycardia is significantly associated with adverse outcomes and should not be dismissed as a normal variant. Identifying patients at an increased risk of having an underlying complication can help guide interpretation, workup, and management of postoperative patients in the head and neck population.

PMID: 30717618 [PubMed - indexed for MEDLINE]

16:03

Cancer & Heart (Cardio-Oncology, Cardiotoxicity, TEV)

Photo

Not included, change data exporting settings to download.

256×256, 6.0 KB

16:03

In reply to this message

pubmed: ctoall&ca or conall

Prostaglandin E2 as a Therapeutic Target in Bladder Cancer: From Basic Science to Clinical Trials.


Related Articles

Prostaglandin E2 as a Therapeutic Target in Bladder Cancer: From Basic Science to Clinical Trials.


Prostaglandins Other Lipid Mediat. 2020 Jan 10;:106409


Authors: Woolbright BL, Pilbeam CC, Taylor JA


No comments:

Post a Comment

اكتب تعليق حول الموضوع

728x90'ads

Search This Blog